The Roots of Autism and ADHD Twin Study in Sweden (RATSS) by Bölte, Sven et al.
Twin Research and Human Genetics
Volume 17 Number 3 pp. 164–176 C© The Authors 2014 doi:10.1017/thg.2014.12
The Roots of Autism and ADHD Twin Study in
Sweden (RATSS)
Sven Bo¨lte,1,2 Charlotte Willfors,1 Steve Berggren,1,2 Joakim Norberg,1 Lina Poltrago,1,3
Katell Mevel,1,4,5 Christina Coco,1,2 Peter Fransson,6 Jacqueline Borg,1,6 Rouslan Sitnikov,7
Roberto Toro,8 Kristiina Tammimies,1 Britt-Marie Anderlid,9,10 Ann Nordgren,9,10 Anna Falk,11
Urs Meyer,12 Juha Kere,13 Mikael Lande´n,14,18 Christina Dalman,15 Angelica Ronald,16
Henrik Anckarsa¨ter,17 and Paul Lichtenstein18
1Center of Neurodevelopmental Disorders at Karolinska Institutet, Pediatric Neuropsychiatry Unit, Department of
Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden
2Division of Child and Adolescent Psychiatry, Stockholm County Council, Stockholm, Sweden
3PRIMA Barn- och Vuxenpsykiatri, Stockholm, Sweden
4CNRS U3521, Laboratory for the Psychology of Child Development and Education, Sorbonne, Paris, France
5Paris Descartes University and Sorbonne Paris Cite´, Paris, France
6Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
7MRI Research Center, Neuroradiology Clinic, Karolinska University Hospital, Stockholm, Sweden
8Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France
9Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden
10Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
11Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
12Physiology and Behavior Laboratory, Swiss Federal Institute of Technology (ETH) Zurich, Switzerland
13Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden
14Section of Psychiatry and Neurochemistry, Sahlgrenska Academy, Gothenburg, Sweden
15Public Health Epidemiology, Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden
16Centre for Brain and Cognitive Development, Department of Psychological Sciences, Birkbeck, University of London,
London, UK
17Neuroscience and Physiology, Forensic Psychiatry, University of Gothenburg, Gothenburg, Sweden
18Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Neurodevelopmental disorders affect a substantial minority of the general population. Their origins are
still largely unknown, but a complex interplay of genetic and environmental factors causing disturbances
of the central nervous system’s maturation and a variety of higher cognitive skills is presumed. Only
limited research of rather small sample size and narrow scope has been conducted in neurodevelopmental
disorders using a twin-differences design. The Roots of Autism and ADHD Twin Study in Sweden (RATSS)
is an ongoing project targeting monozygotic twins discordant for categorical or dimensional autistic and
inattentive/hyperactive-impulsive phenotypes as well as other neurodevelopmental disorders, and typically
developing twin controls. Included pairs are 9 years of age or older, and comprehensively assessed for
psychopathology, medical history, neuropsychology, and dysmorphology, as well as structural, functional,
and molecular brain imaging. Specimens are collected for induced pluripotent (iPS) and neuroepithelial
stem cells, genetic, gut bacteria, protein-/monoamine, and electron microscopy analyses. RATSS’s objective
is to generate a launch pad for novel surveys to understand the complexity of genotype-environment-
phenotype interactions in autism spectrum disorder and attention-deficit hyperactivity disorder (ADHD).
By October 2013, RATSS had collected data from 55 twin pairs, among them 10 monozygotic pairs dis-
cordant for autism spectrum disorder, seven for ADHD, and four for other neurodevelopmental disorders.
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This article describes the design, recruitment, data collection, measures, collected pairs’ characteristics, as
well as ongoing and planned analyses in RATSS. Potential gains of the study comprise the identification of
environmentally mediated biomarkers, the emergence of candidates for drug development, translational
modeling, and new leads for prevention of incapacitating outcomes.
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Neurodevelopmental disorders are disturbances of the cen-
tral nervous system’s architecture, processes, and mat-
uration that affect a person’s behavior (e.g., social-
communication and interaction skills, language, attention,
emotions, motor performance, learning, memory) and sig-
nificantly reduce functional adaptive skills in everyday life.
The DSM-5 (APA, 2013) acknowledges the significance of
aberrant neurodevelopment for psychiatry by introducing
the umbrella concept of neurodevelopmental disorders for
the first time (Regier et al., 2009). No good prevalence es-
timates are available for neurodevelopmental disorders in
total, but preliminary survey data from the United States
indicates a frequency of 12% in the general population (Pas-
tor & Reuben, 2009). Currently, increasingly accepted esti-
mates for two of the most prominent neurodevelopmental
disorders, autism spectrum disorder (ASD) and attention-
deficit hyperactivity disorder (ADHD), in school-aged chil-
dren are 1–2% (Idring et al., 2012; Kim et al., 2011) and
5% (Polanczyk et al., 2007), respectively. Males are affected
2–4 times more often than females. ASD and ADHD have
been increasingly diagnosed in the last decade (Froehlich
et al., 2007; Rutter, 2005). Although still debated, improved
knowledge, increased awareness, and better services, as well
as reduced stigmatization, changes in and a more sensitive
interpretation of diagnostic criteria probably account for a
significant proportion of these time trends (Wazana et al.,
2007). Comorbidity is high in ASD and ADHD individuals.
For example, the overlap of ASD and intellectual develop-
mental disorders is in the range of 50% (Fombonne, 2009).
Simonoff et al. (2008) found that 28% of school-aged
children with ASD also fulfill DSM-IV criteria for ADHD
and 9% for chronic tic disorder. A meta-analysis of ADHD
yielded a 10.7-fold risk for conduct disorder, 5.5-fold for
depression, and 3.0-fold for anxiety disorder (Angold et al.,
1999).
ASD and ADHD have many causes, but most evidence
suggest that they are highly heritable and show modest non-
shared environmental influence, that is, environmental in-
fluences that make children growing up in the same family
different (Chang et al., 2013; Lichtenstein et al., 2010). Aside
from clinically relevant phenotypes qualifying for a cate-
gorical diagnosis, data increasingly support the notion of
broader/extended phenotypes and traits of ASD and ADHD
that are continuously distributed in the general population
(Constantino & Todd, 2003; Normand et al., 2012), with
their variation determined by factors overlapping with clin-
ical phenotypes (Robinson et al., 2011; Larsson et al., 2012;
Lundstro¨m et al., 2012). Heritability estimates, predomi-
nantly from twin research, indicate that genetic factors ac-
count for80% of symptom variation in ASD and ADHD
(Ronald & Hoekstra, 2011; Taylor et al., 2013; Wadsworth
et al., 2007; Wood & Neale, 2010), as well as ASD-like and
ADHD-like traits (e.g., Constantino et al., 2003). In addi-
tion, behavior and molecular studies indicate partly over-
lapping genetic components for both disorders (e.g., Heiser
et al., 2004; Moreno-De-Luca et al., 2013; Reiersen et al.,
2008; Ronald et al., 2008; Taylor et al., 2013).
The genetics of ASD and ADHD are complex. In 10% of
individuals with ASD an identifiable single-gene disorder,
such as fragile X, tuberous sclerosis or neurofibromato-
sis exists, which may account for the phenotype. In ad-
dition, 5–10% have known chromosomal rearrangements
such as maternally inherited duplications of 15q11-q13, in-
herited or non-inherited (de novo) copy number variations
(CNVs), predominantly in genes with synaptic functions
(e.g., NLGN3, NLGN4, NEUREXIN1, SHANK3, and CNT-
NAP2; Persico & Napolioni, 2013). These findings, cou-
pled with genome sequencing data, suggest the existence
of hundreds of ASD risk genes (Devlin & Scherer, 2012).
To date, ADHD studies have reported substantial evidence
implicating several genes, including those in the dopamin-
ergic (DRD4, DAT1, DRD5, COMT), noradrenergic (DBH,
ADRA2A), serotonergic (5-HTT, HTR1B, HTR2A), cholin-
ergic (CHRNA4), and central nervous system development
(SNAP25, BDNF) pathways (Caylak, 2012).
Even though ASD and ADHD are highly genetic, the
causes are multifactorial, and environmental influences
also play an important role in susceptibility, with non-
shared environment consistently reported in twin studies
of ASD, ADHD, and their related traits (Ronald & Hoek-
stra, 2011). Environmental factors may act via epigenetic
mechanisms, that is, modifications of gene expression con-
trolled by something other than the DNA sequence that
are potentially reversible. These factors are influenced by
the maturational stage, tissue type, and environment. Evi-
dence suggests that dysregulation of epigenetic markers or
mechanisms, such as DNA methylation, plays an important
role in ASD and ADHD and integrates genetic and envi-
ronmental influences to dysregulate neurodevelopmental
processes (Grafodatskaya et al., 2010; Smith et al., 2009).
Environmental factors may play a role in the inception and
lifelong modulation of ASD (Herbert, 2010). Some gene
variants in ASD confer altered vulnerability to environ-
mental stressors and exposures (Levy et al., 2009). Random
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de novo mutations increasing with advanced parental age
are stochastic risk factors for ASD, suggesting a role of the
environment (Parner et al., 2012). The systemic and central
nervous system pathophysiology in ASD, including oxida-
tive stress, neuroinflammation, and mitochondrial dysfunc-
tion, can be consistent with environmental influence (e.g.,
air pollution, organophosphates, or heavy metals; Chauhan
& Chauhan, 2006; Jung et al., 2013) and some of the under-
lying biochemical disturbances (e.g., abnormalities in glu-
tathione, a critical antioxidant and detoxifier, might be re-
versed by targeted nutritional interventions; Geraghty et al.,
2010). Dietary factors and food contaminants may con-
tribute to the risk. Similarly, the environmental risk factors
for ADHD include prenatal exposure to substances, expo-
sure to heavy metals and chemicals, nutritional factors, and
lifestyle/psychosocial factors (Froehlich et al., 2011).
As indicated by the designation ‘neurodevelopmental
disorder’, genetic, epigenetic, and environmental factors
detrimentally affect neurobiological and neurocognitive de-
velopment and maturation. In ASD, macrocephaly is noted
by age 12 to 24 months in a substantial proportion of chil-
dren (Courchesne et al., 2011). Structural neuroimaging
studies demonstrate alterations in both cortical and white
matter regions, together with abnormal patterns of growth
mainly localized in the frontal lobe, temporal lobes, and
limbic structures, such as the amygdala. Diffusion tensor
imaging has demonstrated the disruption of white matter
fiber bundle connecting brain regions associated with var-
ious high-level cognitive functions (e.g., social cognition,
language). Functional neuroimaging studies have found al-
terations in activation and synchrony across cortical net-
works, with reduced functional connectivity relating to a
variety of cognitive functions, including language, working
memory, social cognition or perception, and problem solv-
ing (Vissers et al., 2012). Neurochemical investigations with
animal models and empirical drug studies remain incon-
clusive. Genetic differences in serotonin transport seem to
have the most empirical evidence for a role in ASD, whereas
data lending support to a role of the dopaminergic and glu-
taminergic systems are presently less robust, but evolving
(Geschwind & Levitt, 2007).
Taken together, the results thus far indicate that ASD
is characterized by a neuronal-cortical organization im-
pacting on developmental trajectory of social cognition
(including social attention and social orientation; Senju,
2013), executive function, and problem-solving mindset
(Levy et al., 2009), and top-down versus bottom-up in-
formation processing with the integration of information
into meaningful gestalt (Bo¨lte et al., 2007; Dziobek & Bo¨lte,
2011). These findings tie in with behavior genetic research
that suggests that the triad of impairments that characterize
ASD may have partly different causal pathways (e.g., Happe´
& Ronald, 2008; Ronald et al., 2011). Neurobiological al-
terations are widespread in ADHD, with the most signif-
icant and consistent structural imaging findings pointing
to smaller total brain volumes and reduced volumes in the
right frontal lobe, right parietal cortex, caudate nucleus,
cerebellar hemispheres, and posterior-inferior lobules of
the cerebellar vermis (Tripp & Wickens, 2009). Neurochem-
ically, ADHD involves hypofunctioning of catecholaminer-
gic circuits, particularly those that project to the prefrontal
cortex (Durston, 2008). On the cognitive level, a triple
pathway model of ADHD is favored, with impairment in
executive control/inhibition, motivation (delay-aversion),
and timing as dissociable neuropsychological components
(Sonuga-Barke et al., 2010).
As described above, the understanding of the poten-
tial causes of neurodevelopmental disorders, most notably
ASD and ADHD, has significantly increased. Still, knowl-
edge regarding their etiology and pathophysiology is far
from complete. The genetic, epigenetic, and environmental
mechanisms driving neurodevelopmental phenotypes re-
main poorly understood. Outcome variability, evidence of
a treatment response to a variety of interventions, and the
possibility of improvement in ASD and ADHD suggest that
the brain circuitry is amenable to epigenetic/environmental
modulation. Thus, targets need to be sought for early
biopsychosocial prevention and treatment. However, ASD
and ADHD research so far has several limitations. First,
most studies are based on cases versus typical controls only,
which does not allow conclusions about causality. Second,
many studies are one-dimensional, focusing on the asso-
ciations between narrow aspects of psychopathology and
(epi-)genetics, environment, neurobiology, or neuropsy-
chology. Third, studies have mostly looked at behavioral
ASD and ADHD phenotypes categorically (as clinical di-
agnoses), rather than dimensionally (as traits), and almost
never jointly. Fourth, DSM-IV and ICD-10 include mutual
diagnostic exclusion criteria for ASD and ADHD, which
hampered appropriate research on conditions with high
comorbidity.
With this project, we seek to overcome many of these
shortcomings in order to generate a launch pad for pio-
neering, novel evidence in understanding the complexity
of ASD and ADHD. For this purpose, the largest cohort
ever of monozygotic (MZ) twins discordant or concor-
dant for carefully characterized clinical and subthreshold
ASD and ADHD phenotypes, as well as typically devel-
oped controls, will be investigated in concert with multidi-
mensional, simultaneous assessments and combined ana-
lytical approaches, comprising medical history, comorbid-
ity, neuropsychology, dysmorphology, collection of neu-
roepithelial stem (NES) cells and specimens for (epi-
)genetic, neurotoxic, gut bacteria, protein-/monoamine,
electron microscopy analyses, and multimodal neuroimag-
ing (e.g., structural, functional, and molecular investiga-
tions). We hypothesize subtle, but specific differences within
discordant monozygotic ASD and ADHD pairs on mul-
tiple biological and behavioral levels of assessment that
will be informative for deciphering the complexity of
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genotype-environment-phenotype correlations, especially
those related to non-shared environment.
Materials and Methods
Design
Roots of Autism and ADHD Twin Study in Sweden (RATSS)
uses the co-twin control or twin-differences design (Mar-
tin et al., 1997). Only a moderate number of studies have
specifically addressed discordant MZ twin pairs for ASD
(e.g., Hu et al., 2006; Kates et al., 1998, 2004, 2009; Mitchell
et al., 2009; Wong et al., in press), ADHD (e.g., Castellanos
et al., 2003; Lehn et al., 2007; Pearsall-Jones et al., 2008,
2009; Sharp et al., 2003; van’t Ent et al., 2009) or traits of
both disorders (e.g., Groen-Blokhuis et al., 2011; Ronald
et al., 2010). The findings have been promising, indicating
medical history (e.g., ADHD: low birth weight and delayed
physical growth/motor development in cases), neuromor-
phological differences (e.g., ASD: reduced caudate, amyg-
dala, hippocampus, and cerebellar volumes, differences in
cortical folding within the partial lobe; ADHD: reduced
caudate nucleus and prefrontal lobe volumes in cases), and
differential gene expression patterns on DNA microarrays
(e.g., ASD: ASS, NAGLU, FLAP, and ROBO I) in the af-
fected twin. The current project will elaborate upon these
works using an integrated, comprehensive assessment ap-
proach in a significantly larger cohort, providing the option
of cross-disciplinary analyses.
In RATSS, we predict that the affected co-twins, com-
pared to the unaffected co-twins, in MZ pairs discordant
for ASD and ADHD will exhibit de novo mutations, such
as single nucleotide variations (SNVs) or CNVs in genes
crucial for neurodevelopment, differences in methylation
at selected genes or overall epigenome, and environmental
factors as a possible source of epigenetic and phenotypic
variation. In addition, we expect these differences to be
associated with functional and structural neurobiological
characteristics, particularly over- and under-connectivity in
ASD, and eventually in ADHD (Konrad & Eickhoff, 2010),
as well as with molecular brain characteristics (e.g., GABA
(gamma-aminobutyric acid), glutamate dysregulation). We
also hypothesize that these mechanisms correlate with cog-
nitive phenotypes (e.g., ASD: social cognition, attention
to detail, flexibility, planning; ADHD: working memory,
inhibition, timing, reward dependence), with categorically
and dimensionally defined ASD/ADHD and ASD/ADHD
symptoms, and with functional impairment. Finally, we
predict that these findings will emerge as specific com-
pared to typical controls, and partly specific to ASD or
ADHD.
Participants
The long-term objective of the study is to collect 50 MZ pairs
qualitatively or markedly quantitatively discordant for ASD
or broader autism phenotype/autism traits, as well as 50 MZ
pairs qualitatively or markedly quantitatively discordant for
either ADHD or broader ADHD phenotype/symptoms, all
aged 8 to 50 years. In addition, the studies aim to include 30
MZ pairs concordant for each ASD and ADHD, and 40 MZ
typically developed control pairs, and 40 MZ pairs discor-
dant for other neurodevelopmental disorders. Twin zygosity
is determined on a panel of 48 single nucleotide polymor-
phisms (SNPs; Hannelius et al., 2007). A more balanced gen-
der distribution than in the general population is aimed to
be accomplished in order to allow gender-specific research.
Exclusion criteria for all participants are profound intellec-
tual disability (IQ< 35), serious psychiatric (e.g., paranoid
schizophrenia) or neurological (intractable epilepsy) con-
ditions, or any well-defined genetic syndrome (e.g., frag-
ile X). Additional exclusion criteria will apply for certain
assessments, such as metallic implants, brain surgery, or
claustrophobia for magnetic resonance (MR) neuroimag-
ing. Inclusion criteria for ASD will be an ICD-10-defined
diagnosis of autism (F84.0), Asperger syndrome (F84.5), or
atypical autism/PDD-NOS (F84.1, F84.8, F84.9), or a DSM-
5 diagnosis of ASD. For ADHD, the inclusion criteria will
be any ICD-10-defined diagnosis of hyperkinetic disorder
(F90.0-F90.9) or DSM-5 diagnosis of ADHD (combined,
inattentive, or hyperactive-impulsive subtype). Qualitative
discordancy is defined as a main diagnosis of ASD or ADHD
in twin 1, and either no diagnosis (typical developmental)
or a different main diagnosis in the co-twin. Marked quan-
titative discordancy is defined by: (1) both twins having a
diagnosis in the same diagnostic group but the diagnoses
differ in severity (e.g., autism vs. PDD NOS [ICD-10]; ASD
with different severity specifiers [DSM-5]); (2) twins scor-
ing with 1 SD difference on dimensional ASD (e.g., SRS
and/or AQ) or ADHD (Conners-3 and/or CBCL) scales; (3)
in addition, not stressing clinically striking phenotypic dif-
ferences, the concept of discordancy will also be applied
more flexibly and exploratory using smaller differences
of ASD-like, ADHD-like, and other neurodevelopmental
traits.
Twins are currently being recruited from four sources:
(1) the primary resource is the Child and Adolescent Twin
Study in Sweden (CATSS; Anckarsa¨ter et al., 2011) tar-
geting all twins born in Sweden since 1994; the response
rate for CATSS is approximately 80%, with >25,000 twins
born between 1993 and 2004; (2) the patient registry of
the Swedish Board of Health and Welfare; (3) the clini-
cal registries of the Division of Child and Adolescent Psy-
chiatry, the Habilitation and Health centers, and pediatric
units in Stockholm County; (4) summons in the journals
of the National Society for neurodevelopmental disorders
(Riksfo¨rbundet Attention; 13,000 members), the National
Society for Autism and Asperger syndrome (Autism och
Aspergerfo¨reningen; 12,000 members), and the national
twin organization (Tvillingklubben), exhibitions at their
(bi-)annual meetings, and other forms of media (e.g., re-
ports on the project in newspapers and on television).
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Procedure and Measures
Assessments within RATSS are comprehensive, lasting up
to 3 days and with participants recruited from all over Swe-
den. Participants are continuously accompanied by an ex-
perienced research nurse from the first contact to the end
of the assessments. In case of identification of yet unde-
tected psychiatric or medical problems or the emergence
of adverse effects connected to the assessments, the project
team can adequately and swiftly provide or refer to services.
Assessments are carried out in Stockholm, Sweden, by expe-
rienced clinical staff (nurses, psychologists, and physicians)
at the Astrid Lindgren Children’s Hospital, the Center of
Neurodevelopmental Disorders at Karolinska Institutet, the
Karolinska Institutet Neuroimaging Center, and St. Go¨rans
Hospital. Questionnaires are collected by mail before face-
to-face assessments in order to limit the burden of the study.
Biosamples are primarily collected from participants during
the visits, but also via express service (e.g., saliva, feces).
Diagnosis, general psychopathology. MZ twins with sus-
picion of a previous clinically confirmed diagnosis of
ASD or ADHD are followed up to corroborate the sus-
picion/diagnosis and create comparable clinical data. For
ASD, the Swedish forms of Autism Diagnostic Interview –
Revised (ADI-R) and the Autism Diagnostic Observation
Schedule (ADOS-2) are used (note that the first author
is a certified ADOS and ADI-R trainer). A diagnosis of
ADHD is established using the Kiddie Schedule for Affec-
tive Disorders and Schizophrenia (K-SADS) or the Diag-
nostic Interview for ADHD in adults (DIVA). The K-SADS
is also used to examine psychiatric comorbidity in both
ASD and ADHD. In adults, the Structured Clinical Inter-
view for DSM-IV (SCID, axis I) is collected to assess co-
morbidity. Additional ASD measures collected in all twins
are the (parent report) Social Responsiveness Scale (SRS;
or adult version, SRS-A) and the Autism Spectrum Quo-
tient (AQ; or AQ-children). The parent report Conners 3
and the Adult ADHD Self Report Scale are used to quan-
tify ADHD. To assess and quantify general psychopathol-
ogy, age-appropriate versions of the Achenbach Scales (e.g.,
Child Behavior Checklist, Young Adult Behavior Check-
list) are collected. The Children’s Communication Checklist
(or Communication Checklist for Adults), Sensory Profile
for children or adults, and Adaptive Behavior Assessment
Scale-II are obtained for additional psychopathological and
functional phenotypic assessment.
Cognition. Cognitive testing comprises different versions
of the children’s or adult Wechsler IQ (WISC-IV, WAIS-IV)
or Leiter scales, and the Peabody Picture Vocabulary Test
(in the case of low/borderline intellectual functioning) for
general and verbal abilities in all participants. The Reading
Mind in the Eyes Test and Movie for the Assessment of
Social Cognition are collected for social cognition in ASD
and ADHD. The Fragmented Picture Test and (Children’s)
Embedded Figures Test are administered for attention to
detail/central coherence, and the Tower Test (in D-KEFS)
and Wisconsin Card Sorting Test for executive problems
in terms of foresighted planning and cognitive flexibility in
ASD. The Corsi Block Test for visuospatial working memory
(also Digit Span of the Wechsler will be available for verbal
working memory), the Conner’s Continuous Performance
Test for sustained and selective attention and inhibition, a
modified go/no-go task for timing, and the choice delay
task for delay aversion are used to test executive problems
in ADHD.
Medical history. Comprehensive anamnesis and socio-
demographic information are collected, including details
on familial burden, pregnancy, mother’s health and habits,
obstetric complications, early nutrition/breastfeeding, vi-
ral infections, allergies, food intolerances, medication, par-
ents’ socio-economic status and education, school prob-
lems, and diagnostic and therapeutic procedures. Existing
clinical records are also reviewed.
Dysmorphology, specimens. Signs of dysmorphology are
examined thoroughly by two experienced clinical geneti-
cists, and photographs of the face, hands, feet, and habitus
are taken by a professional clinical photographer for quan-
titative dysmorphology analyses. Samples of blood, saliva,
skin, cerebrospinal fluid (CSF), urine, baby teeth (if avail-
able, for toxicity; e.g., metals analysis; not described in detail
in this proposal), and stool are collected.
Neuroimaging. If the preliminary safety questionnaire re-
veals no exclusion criterion, an 50-minute session in a 3
Tesla MR750 GE scanner at the Karolinska Institutet MR
center is conducted. A 32-channel coil array is used and the
participants’ head position fixed with foam pads to mini-
mize movement. This MR session includes a T1-weighted
Inversion Recovery Fast Spoiled Gradient Echo (IR-FSPGR)
3D-volume, two 60-direction Diffusion Weighted Imaging
(DWI) sequences (b-value of 1,000 and 3,000 s/mm2), and
a resting-state session including 200 T2-weighted Echo Pla-
nar Image (EPIs) volumes. In addition, a T2-weighted Fluid
Attenuated Inversion Recovery (FLAIR) volume is acquired
and checked by an experienced neuroradiologist. With re-
gard to metabolic imaging (MR Spectroscopy; MRS), we
will soon add a second session using the same 3T GE
scanner with an 8-channel coil array. A Mescher-Garwood
point-resolved spectroscopy (MEGA-PRESS) sequence will
be used. Volumes of interest (VOI) of 8 to 15 mL will be
accurately positioned on two-to-three brain major network
nodes using a T1-weighted IR-FSPGR volume (see above
for details).
Analyses
We predict differences between affected MZ twins with ASD
or ADHD (and pairs discordant for lesser phenotypes) and
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their unaffected, less affected, or differently affected co-
twins with regard to medical history, signs of dysmorphol-
ogy, psychiatric comorbidity, and neurocognition. Those
characteristics are not present in the concordant MZ pairs
and other typically developing MZ pairs, hence indicating
non-shared risks. In addition, we hypothesize additional
differences with regard to these parameters between con-
cordant ASD and ADHD MZ pairs and MZ typically devel-
oped pairs, in turn (indicating shared risks for neurodevel-
opmental disorders). Results from these analyses will help
us understand the genetic and epigenetic, CSF, microbiota,
and neurobiological findings (see below), as well as generate
more phenotype-based, hypotheses-driven studies.
The primary objective of the brain imaging part of RATSS
is to examine the ‘brain connectome’ in ASD and ADHD.
This model allows us to map and understand in vivo the
structural and functional neural connections forming the
brain at the network level (Sporns et al., 2005). As for
the ASD affected individuals, overall, we expect either a
mixed pattern of local over-connectivity and long-distance
under-connectivity (of the frontal lobe mainly; Courchesne
& Pierce, 2005), or a differently organized network topology.
For ADHD, a hypotheses-free exploratory approach will be
applied. The secondary aim of the neurobiological investi-
gations is to complete the brain connectome approach with
morphometric and further functional (e.g., MRS) investi-
gations. With regard to morphometry, RATSS will analyze,
on a whole-brain basis, gray/white matter volumetry, cor-
tical folding (gyrification) patterns, cortical thickness, and
sulcal morphometry indices to provide a characterization
of the ASD and ADHD cerebral patterns. These can be used
as biomarkers in individuals with neurodevelopmental dis-
orders (e.g., Shokouhi et al, 2012). 1H-MRS is a promising
tool for identifying metabolic biomarkers in neurodevelop-
mental disorders. Several MRS voxels will be positioned on
major brain nodes, either suspected to be associated to ab-
normal neuronal processing (e.g. under- or over-functional
or structural connectivity) or to demonstrate significant
anatomical differences. Among the major hallmarks of 1H-
MRS spectra in human brain, the glutamate, glutamine
(Glu, Gln, often Glu + Gln = Glx), and GABA are the most
relevant for RATSS as they reflect the equilibrium between
the excitatory and inhibitory neurotransmission systems,
which in turn can be specific to certain network nodes. In
addition, these metabolites are involved not only in signal
transduction, but also brain maturation and cortical or-
ganization, especially neuronal migration and positioning,
which is of high relevance for neurodevelopmental disor-
ders. Accordingly, GABA and glutamate have been found to
be involved in the pathophysiology of neurodevelopmental
disorder, particularly ASD (e.g., DeVito et al., 2007; Ecker
et al., 2013; Pardo & Eberhart, 2007).
CSF is more likely than blood to contain potential mark-
ers of disorders in the central nervous system because the
chemical properties of CSF more closely reflect the bio-
chemistry of the brain. CSF markers have the potential to act
as diagnostics tools but can also function as predictors for
treatment response, side effects, and/or disease progression
(Perlis, 2011). CSF-based neurochemical diagnostics have
been successfully developed for other neurological disor-
ders (e.g., Alzheimer’s disease), but not ASD or ADHD. In
RATSS, established biomarkers of neurodegeneration, brain
injury, synaptic function, inflammation, and monoamines
will be assessed in CSF. The limitation with this candidate
marker approach is, however, that we are limited to a set of
tools that we already know are of some importance. We will
therefore complement these analyses with an approach that
is better suited to detect novel markers that may advance
the field: hypothesis-free combined proteomics and pep-
tidomics for the global analysis of proteins and endogenous
peptides in CSF. New mass spectrometry-based proteomic
techniques are now allowing researchers to detect and iden-
tify hundreds of biomolecules in a single analysis of minute
biological samples. These techniques enable a more unprej-
udiced research approach that may lead to the discovery of
novel molecules involved in disease, as well as disease mech-
anisms that involve co-action of several molecules. Several
research articles in the last few years indicate the feasibility
to employ these techniques in the discovery of biomark-
ers in CSF. By subtracting the protein/peptide pattern of
the typical co-twins from that of the affected ASD/ADHD
twin, we hope to identify proteins that are only present in
a clinical/subclinical neurodevelopmental disorder pheno-
type (see Ho¨ltta¨ et al., 2012; Kroksveen et al., 2011).
Induced pluripotent stem (iPS) cells and iPS-derived
NES cells from patients are ideal building blocks for the
development of disease-specific cellular models (Falk et al.,
2012). Cellular models built on patient-specific iPS cells
have successfully shown disease phenotypes, also when
modeling psychiatric disorders (Christian et al., 2012; Park
et al., 2008). The few reprogramming studies of cells from
patients with psychiatric disorders have had encouraging
results, proving the principle, as well as presenting possi-
ble molecular mechanisms. For example, calcium Ca(v)1.2
has been suggested to regulate the differentiation of cortical
neurons in humans and offer new insights into the causes
of autism in individuals with Timothy syndrome (Pasca
et al., 2011). We will use the skin biopsies from MZ pairs
discordant for ASD or ADHD, to derive iPS and NES cells
that are further differentiated into disease-relevant neurons.
The advantage of using NES cells instead of iPS cells as a
starting cell line for directed differentiation is that NES cells
only differentiate into neural cell types (neurons and glia)
and no cells from other germ layers will disturb differen-
tiation. In addition, the differentiation protocol will span
two weeks instead of 5–6 weeks. Protocols will be devel-
oped for deriving neuronal subtypes known to be affected
in neurodevelopmental disorders, such as cortical neurons
and GABAergic interneurons. The literature provides good
insight into signaling molecules important for these fates
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(Jagatha et al., 2009). To investigate the mechanisms causing
neurodevelopmental disorders, mutated patient NES cells
are studied side by side with healthy NES cells using assays
reporting proliferation, differentiation, migration, matura-
tion, and survival of neural cells.
Our primary hypothesis in RATSS is that the symptoms
in the affected twin are caused by epigenetic and genetic
differences between the twins. To identify the putative dif-
ferences, a broad range of genetic analyses, including high-
density DNA microarrays and whole exome and genome se-
quencing (WES and WGS, respectively) will be performed.
First, the discordant twin pairs will be screened for their
CNV status using high-resolution DNA microarrays. To
identify putative pathogenic variants, the CNVs from twins
with ASD or ADHD will be compared to control twins and
other available controls. Then, WES and/or WGS of the
twins and their parents will be used to pinpoint rare and/or
de novo mutations, including mosaic mutations. To identify
any epigenetic differences between the twins, a microarray-
based global methylation analysis will be performed using
the collected blood samples. Any identified differentially
methylated regions will be confirmed by pyrosequencing.
Furthermore, we can correlate the methylation status to
gene expression in blood-derived ribonucleic acid (RNA)
using quantitative Reverse Transcriptase Polymerase Chain
Reaction (qRT-PCR) (selected genes) or RNA sequencing
(global gene expression). For some of the twins, we will be
able to measure the methylation status at birth from dried
blood spots and detect persistent methylation differences or
changes in methylation status during childhood that could
contribute to symptoms seen in the affected twin.
In addition to the clinical manifestations typically associ-
ated with central nervous system (CNS) dysfunctions, ASD
(and to a lesser extent ADHD) has been frequently linked to
various gastrointestinal (GI) symptoms such as abdominal
pain, constipation, diarrhea, enterocolitis, and abnormal
intestinal permeability (Kral et al., 2013). GI functions are
critically dependent on the integrity and diversity of the gut
microbiota, that is, the collection of commensal microor-
ganisms that colonize the GI tract. It has therefore been
suggested that at least parts of the GI symptoms in ASD may
stem from alterations in gut microbiota, and such micro-
bial changes may be amenable to therapeutic interventions
that could improve the general life qualities of affected in-
dividuals (De Angelis et al., 2013). The gut microbiota has
further emerged as an important functional node within the
gut-brain axis, which in turn functionally interconnects the
viscera, including the GI tract, with the CNS (Mayer, 2012).
One of the burning questions in this context is whether
GI- and CNS-associated symptoms in neurodevelopmental
disorders such as ASD are two separate pathological en-
tities, or whether they are causally related. Owing to the
constant bidirectional information flow between the gut
and the brain, it is indeed feasible to assume that GI dis-
turbances may causally contribute to at least some brain
dysfunctions (Reichelt & Knivsberg, 2009). In RATSS, we
test the hypothesis that primary alterations in the gut micro-
biota not only facilitates the emergence of GI dysfunction,
but also impacts brain and behavioral functions via changes
in afferent vagal signaling, gut immunity, and/or altered se-
cretion of neuroactive substances. In the current project,
the nature of microbiotic changes in fecal samples obtained
from twins affected by ASD and ADHD are compared to
the microflora of their unaffected co-twins. Potential dif-
ferences in the microbiota between twins and co-twins are
related to differences in psychopathology, cognition, and
functional and structural neuroimaging findings, as a well
as CSF biomarkers, genetics, and epigenetics.
Results
The RATSS data collection began in mid-2011. As of Octo-
ber 2013, N = 109 individuals (68 males, 41 females) from
54 twin-pairs and one set of triplets (Figure 1) have been
assessed using the RATSS protocol, and an additional eight
pairs are scheduled for 2013. Eighty-two are MZ, 20 dizy-
gotic (DZ), and zygosity is pending in eight individuals. In
three twin pairs, twin-to-twin transfusion syndrome was
reported. The average age is 15.0 years (SD = 3.2, range =
9–23); the average IQ is 93.3 (SD = 18.9, range = 39–138).
Sixty-six percent of the sample has been recruited via the
CATSS study, 28% via advertisements, 4% from clinical unit
(e.g., child psychiatry), and 2% from the Swedish patient
registry.
Ten MZ twin-pairs are qualitatively or markedly quan-
titatively discordant for ASD and seven for ADHD. Please
note that where one twin was diagnosed with ASD and the
co-twin with ADHD, twin pairs were assigned to the ASD
discordant pairs count. One additional pair pending for
zygosity testing results, at the time of the writing of this
article, was highly likely to be MZ and discordant for ASD
(Table 1). Moreover, the sample includes four MZ pairs
discordant for other neurodevelopmental disorders (intel-
lectual disability, tic disorder, speech sound disorder), and
four MZ pairs concordant for ASD or ADHD.
Overall, the completeness and usability of the collected
data and specimens is adequate (Figure 2). Data for psychi-
atric and psychological assessments are almost complete,
and so are samples of blood, saliva, hair, nails, and urine
(>99%). Coverage is somewhat lower for dysmorphology
examination, extensive medical history taking (93%), and
magnetic resonance imaging (MRI; 88%). Coverage is low-
est for CSF (63%) and skin biopsies (55%). However, the
collection of skin samples was only introduced 1 year ago.
With regard to parental data and specimens, RATSS has al-
most complete questionnaire data on mothers and fathers
(89%), as well as a good coverage for mothers’ (93%) and
fathers’ blood (59%) and saliva (98% and 83%; Figure 3).
Current ongoing analyses focus on differences in execu-
tive functioning in MZ twins discordant for ADHD traits,
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TABLE 1
List of monozygotic twin pairs discordant for autism spectrum disorder, ADHD, and other neurodevelopmental disorders
(DSM-5/ICD-10 diagnoses) in RATSS
Twin 1: primary diagnosis (DSM-5/ICD-10) Twin 2: primary diagnosis (DSM-5/ICD-10) Qualitative/quantitative discordance
ASD/PDD NOS None ASD discordant pairs (n = 10)
ASD/PDD NOS None
ASD/PDD NOS None
ASD/PDD NOS None
ASD/PDD NOS None
ASD/PDD NOS None
ASD/Autism ASD/Asperger syndrome
ASD/Autism ADHD/hyperkinetic disorder
ASD/Asperger syndrome Social anxiety disorder/social phobia
ASD/PDD NOS Mild mental retardation/mild intellectual
disability
ADHD hyperactive-impulsive/hyperkinetic
disorder NOS
None ADHD discordant pairs (n = 7)
ADHD unspecified/hyperkinetic disorder NOS None
ADHD unspecified/hyperkinetic disorder NOS Tic disorder, unspecified/Tic NOS
ADHD unspecified/hyperkinetic disorder NOS Specific phobia/specific phobia
ADHD combined/hyperkinetic syndrome ADHD inattentive/hyperkinetic disorder NOS
ADHD combined/hyperkinetic syndrome ADHD inattentive/hyperkinetic disorder NOS
ADHD combined/hyperkinetic syndrome ADHD unspecified/hyperkinetic disorder NOS
Mild mental retardation/mild intellectual
disability
None Other NDD discordant pairs (n = 4)
Speech sound disorder/phonological disorder None
Tic disorder, unspecified/Tic NOS None
Mild mental retardation/mild intellectual
disability
Speech sound disorder/phonological disorder
ASD/PDD NOS None Pending for zygosity (n = 1)
Note: DSM = Diagnostic and Statistical Manual of Mental Disorders; ICD = International Classification of Diseases; ASD = autism spectrum disorder;
ADHD = attention-deficit hyperactivity disorder; PDD NOS = pervasive developmental disorder not otherwise specified; NOS = not otherwise
specified; NDD = neurodevelopmental disorders.
55
10
7
4
5
14
10
5
0
55
Total nr* MZ disc. ASD MZ disc.
ADHD
MZ disc.
other NDD
MZ conc.
ASD/ADHD
MZ typically
dev.
DZ disc/conc
NDD
Pending for
zygosity
Addional 8 pairs are 
scheduled in 2013
FIGURE 1
Number and type of twin-pairs collected in RATSS on October 9, 2013. Note: ∗Including one trio of triplets, counted as two pairs.
ASD = autism spectrum disorder; ADHD = attention-deficit hyperactivity disorder; DZ = dizygotic; MZ = monozygotic; NDD = neu-
rodevelopmental disorders; TD = typically developed.
including the role of age and gender effects in 27 pairs; a
detailed descriptive comparison analysis of the nine MZ
pairs discordant for ASD. Brain imaging data analyses focus
on the structural connectome (mapping whole-brain white
matter bundles), observed in the most discordant ASD and
ADHD MZ twin pairs, as well as morphometric investiga-
tions; for example, cortical surface reconstructions, analyses
of cortical thickness, cortical folding and gray/white matter
contrast (a proxy of myelination), volumetry of subcortical
structures at the sample level. CSF analyses focus on the
TWIN RESEARCH AND HUMAN GENETICS 171
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/thg.2014.12
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 16:41:49, subject to the Cambridge Core terms of use, available at
Sven Bo¨lte et al.
109
108
97
109
109
109
60
69
96
109
101
0 50 100
Blood
Saliva
Stool
Hair
Nails
Urine
Skin
CSF
MRI
BA*
MDA
Nr of parcipants
giving samples
FIGURE 2
Completeness of twin pair assessments and specimen collections
in RATSS. Note: ∗Minimum assessment = verbal and nonverbal
IQ + Autism Diagnostic Observation Scale (ADOS) + parent re-
port. MDA = medical and dysmorphologic assessment; BA = be-
havioral assessment; MRI = magnetic resonance imaging; CSF =
cerebrospinal fluid.
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FIGURE 3
Completeness of parents’ assessments and specimen collections
in RATSS. Note: ∗Questionnaires = Autism Quotient & Adult Self
Report.
inflammatory markers and markers of brain injury. All the
collected twins will be genotyped using Infinium Human-
CoreExome chip with additional 50K SNPs relevant for
psychiatric disorders (PsychChip). This platform will al-
low detection of CNVs larger than 30 kb in addition to 387
CNVs found to be associated with different psychiatric con-
ditions and enable us to explore the association of SNPs and
different behavioral, cognitive, and neurobiological pheno-
types of the twins. Exome sequencing is planned for the
most clinically discordant pairs for ASD, ADHD, and other
neurodevelopmental disorders together with their parents.
Conclusions
RATSS is the largest multilevel clinical study of ASD and
ADHD and their broader phenotypes and traits, using MZ
twins. The project has already generated a rich collection
of data to be used in a variety of analyses described in this
article. The project will shortly have access to new options
of recruitment via clinically based registries in Stockholm
County (Division of Child and Adolescent Psychiatry, Ha-
bilitation and Health Centers, Pediatrics) to markedly in-
crease the number and ‘clinicalness’ of the twin pair collec-
tion. Overall, there is good likelihood that the project will
be successful in doubling or tripling the amount of twins
and material in the next 2–3 years. For 2015, it is planned
to start following up on the collected pairs, beginning with
the most informative (discordant clinical ASD and ADHD)
pairs, in order to establish the longitudinal arm of RATSS.
Recently, parts of RATSS joined EU-AIMS: European
Autism Interventions — a multicenter study for developing
new medication. The involvement in EU-AIMS will create
synergies, as well as higher research output and visibility of
RATSS. The engagement in EU-AIMS also means that ad-
ditional assessments are integrated in RATSS, such as eye-
tracking, questionnaires, cognitive tests, and brain imag-
ing (molecular positron emission tomography — PET).
As RATSS combines several strengths, particularly access to
nation-wide registry data on twins screened for neurodevel-
opmental disorder traits, multilevel assessments, and a mul-
tidisciplinary environment, there is a good chance for novel
leads regarding pathogenic pathways, informative biomark-
ers, and options for treatment and prevention in ASD and
ADHD. There are several techniques developed by collabo-
rators in this project that have never been used in ASD or
ADHD or in twins discordant for these phenotypes, such
as iPS and NES cells, mass spectrometry-based proteomic
techniques analyzing the CSF, and brain connectome ap-
proaches.
Despite all of the advantages of twin studies, there are
some potential limitations, making cross-validation of twin
findings in singletons desirable for endorsing generalizabil-
ity to the total population. Twins are often born premature
and are lighter at birth than singletons, which could com-
promise the ability of twins to represent the general popu-
lation. Some authors have suggested twinning to be a risk
factor for some neurodevelopmental disorders (e.g., ASD),
but this has not been confirmed in large population-based
studies (e.g., Hallmayer et al., 2002); in twin family stud-
ies including siblings that controlled for confounds (e.g.,
parental education, socio-economic status), sibs and twins
did not differ (e.g., for IQ, see Hoekstra et al., 2007).
In conclusion, RATSS provides some unique opportuni-
ties to examine altered development in ASD and ADHD,
hazardous and protective environmental and genetic fac-
tors and their interplay, as well as their effects on neuro-
biology, and cognition. Finally, while RATSS focuses on
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ASD, ADHD, and other neurodevelopmental disorders, the
twin collection offers many opportunities for spin-off re-
search through collaboration with additional medical disci-
plines, as quite a few of the MZ twin-pairs show discordance
for other medical conditions, such as epilepsy, deafness, or
asthma.
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